Status:
COMPLETED
A Case Control Study to Define Clinical, Immunologic and Radiographic Features of the Aromatase Inhibitor Arthralgia Syndrome
Lead Sponsor:
Victoria Shanmugam
Conditions:
Arthralgia Syndrome
Arthritis
Eligibility:
FEMALE
18+ years
Brief Summary
The CIRAS study will investigate postmenopausal breast cancer patients with hand pain and compare those receiving aromatase inhibitors (cases) to breast cancer patients with hand pain not receiving ar...
Detailed Description
This study is for women with post-menopausal breast cancer and hand pain. Patients do not need to be taking aromatase inhibitors to be eligible for the study. We want to study the joint findings in pa...
Eligibility Criteria
Inclusion
- Postmenopausal women aged over 18 with stage I-III breast cancer undergoing treatment at the Lombardi Cancer Center.
- Presence of hand pain
- No active signs of ongoing malignant disease
Exclusion
- Known autoimmune disease for example, rheumatoid arthritis, systemic lupus erythematosis, polymyalgia rheumatica, or seronegative arthritis.
- Age \<18
- Unable to complete informed consent process
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2010
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00890058
Start Date
April 1 2009
End Date
May 1 2010
Last Update
August 30 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgetown University Hospital
Washington D.C., District of Columbia, United States, 20007